BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10735664)

  • 1. Aggressive multimodality therapy for stage III esophageal cancer: a phase I/II study.
    Alexander EP; Lipman T; Harmon J; Wadleigh R
    Ann Thorac Surg; 2000 Feb; 69(2):363-8. PubMed ID: 10735664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?
    Chan A; Wong A
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):265-70. PubMed ID: 10487544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving management and outcome of esophageal cancer with airway involvement.
    Alexander EP; Trachiotis GD; Lipman TO; Wadleigh RG
    Ann Thorac Surg; 2001 May; 71(5):1640-4. PubMed ID: 11383814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
    Griffin JM; Reed CE; Denlinger CE
    Ann Thorac Surg; 2012 Jun; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
    Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
    Bates BA; Detterbeck FC; Bernard SA; Qaqish BF; Tepper JE
    J Clin Oncol; 1996 Jan; 14(1):156-63. PubMed ID: 8558191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus.
    Jones DR; Detterbeck FC; Egan TM; Parker LA; Bernard SA; Tepper JE
    Ann Thorac Surg; 1997 Jul; 64(1):185-91; discussion 191-2. PubMed ID: 9236358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
    Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
    Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
    El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
    World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of multimodality therapy for resectable esophageal cancer.
    Meneu-Diaz JC; Blazquez LA; Vicente E; Nuño J; Quijano Y; Lopez-Hervás P; Devesa M; Fresneda V
    Am J Surg; 2000 Jun; 179(6):508-13. PubMed ID: 11004342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
    Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
    Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
    Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
    Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration.
    Van Raemdonck D; Van Cutsem E; Menten J; Ectors N; Coosemans W; De Leyn P; Lerut T
    Eur J Cardiothorac Surg; 1997 May; 11(5):828-37. PubMed ID: 9196296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.